Faeth Therapeutics Inc. (FTH)
NASDAQ: FTHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
FTH stock chart
Technical analysisKey statistics
All statistics- Market cap
- $643.94M
- EPS (TTM)
- -$60.86
- Dividend yield
- None
- 52-week range
- 7.45 – 42.14
- Day range
- 23.95 – 27.03
- Volume / Avg
- 322.58K / 348.41K
- Beta
- —
- Shares outstanding
- 25.84M
- Next earnings
- Nov 3, 2026
52-week range
FTH stock today
Shares of Faeth Therapeutics (FTH) finished lower on Oct 7 at $24.92, a drop of 7.33% or $1.97 per share, versus the S&P 500's 0.22% decline. At this level, FTH sits in the middle of its 52-week range of $7.45 to $42.14: 40.9% below the high, set on Sep 8, 2026 and 234.5% above the low. FTH is up 133.6% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 121.4%.
Faeth Therapeutics has posted a net loss over the last twelve months (EPS of -$60.86), so its P/E ratio is not meaningful. Faeth Therapeutics's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Faeth Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- Austin, TX
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 3, 2026
Faeth Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| OLMAOlema Pharmaceuticals Inc. | 7.94 | +0.25% | $694.73M | vs FTH |
| WVEWave Life Sciences Inc. | 3.54 | +0.57% | $697.55M | vs FTH |
| PHARPharming Group N.V. ADS | 9.65 | -0.31% | $683.01M | vs FTH |
| COLLCollegium Pharmaceutical Inc. | 21.93 | +0.23% | $713.94M | vs FTH |
| NVCTNuvectis Pharma Inc. | 20.29 | +1.30% | $662.35M | vs FTH |
| AVTXAvalo Therapeutics Inc. | 13.58 | -0.07% | $728.30M | vs FTH |
| DSGNDesign Therapeutics Inc. | 11.69 | -2.34% | $731.58M | vs FTH |
| ZVRAZevra Therapeutics Inc. | 11.08 | +3.26% | $657.97M | vs FTH |
Indexes, lists and sector
Largest Health Care stocks
Faeth Therapeutics stock FAQ
What is Faeth Therapeutics's stock price today?
FTH last traded at $24.92 as of Oct 7, 4:00 PM EDT, down 7.33% on the day. Prices are delayed at least 15 minutes.
Does Faeth Therapeutics pay a dividend?
No. Faeth Therapeutics does not currently pay a regular cash dividend.
When is Faeth Therapeutics's next earnings date?
Faeth Therapeutics is expected to report earnings on Tuesday, November 3, 2026.
Has FTH ever split its stock?
Yes. The most recent FTH stock split was a 1-for-20 split on Jun 17, 2025.
What is the FTH 52-week high?
The 52-week high for FTH is $42.14 and the 52-week low is $7.45. The stock is currently 40.9% below its high.